173 related articles for article (PubMed ID: 21244342)
1. Safety evaluation of colesevelam therapy to achieve glycemic and lipid goals in type 2 diabetes.
Avitabile N; Banka A; Fonseca VA
Expert Opin Drug Saf; 2011 Mar; 10(2):305-10. PubMed ID: 21244342
[TBL] [Abstract][Full Text] [Related]
2. The role of colesevelam hydrochloride in hypercholesterolemia and type 2 diabetes mellitus.
Brunetti L; Hermes-Desantis ER
Ann Pharmacother; 2010; 44(7-8):1196-206. PubMed ID: 20551301
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of colesevelam in type 2 diabetes mellitus.
Brunetti L; Campbell RK
J Pharm Pract; 2011 Aug; 24(4):417-25. PubMed ID: 21813819
[TBL] [Abstract][Full Text] [Related]
4. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.
Huijgen R; Abbink EJ; Bruckert E; Stalenhoef AF; Imholz BP; Durrington PN; Trip MD; Eriksson M; Visseren FL; Schaefer JR; Kastelein JJ;
Clin Ther; 2010 Apr; 32(4):615-25. PubMed ID: 20435231
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
Davidson M
Clin Ther; 2013 Aug; 35(8):1247-52. PubMed ID: 23916045
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
Goldberg RB; Fonseca VA; Truitt KE; Jones MR
Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
[TBL] [Abstract][Full Text] [Related]
7. Expanded colesevelam administration options with oral suspension formulation for patients with diabetes and hypercholesterolemia.
Dayer-Berenson L; Finckenor M
Postgrad Med; 2014 May; 126(3):126-34. PubMed ID: 24918798
[TBL] [Abstract][Full Text] [Related]
8. What role for [black triangle down] colesevelam in cardiovascular prevention?
Drug Ther Bull; 2009 May; 47(5):53-5. PubMed ID: 19423677
[TBL] [Abstract][Full Text] [Related]
9. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
Bays HE; Davidson M; Jones MR; Abby SL
Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
[TBL] [Abstract][Full Text] [Related]
10. Colesevelam: a new and improved bile acid sequestrant?
Tziomalos K; Karagiannis A; Mikhailidis DP; Athyros VG
Curr Pharm Des; 2013; 19(17):3115-23. PubMed ID: 23317402
[TBL] [Abstract][Full Text] [Related]
11. Colesevelam hydrochloride: a novel bile acid-binding resin.
Aldridge MA; Ito MK
Ann Pharmacother; 2001; 35(7-8):898-907. PubMed ID: 11485143
[TBL] [Abstract][Full Text] [Related]
12. Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
Rosenstock J; Fonseca VA; Garvey WT; Goldberg RB; Handelsman Y; Abby SL; Lai YL; Jin X; Misir S; Nagendran S; Jones MR
Endocr Pract; 2010; 16(4):629-40. PubMed ID: 20634175
[TBL] [Abstract][Full Text] [Related]
13. Colesevelam: in pediatric patients with heterozygous familial hypercholesterolemia.
Perry CM
Paediatr Drugs; 2010 Apr; 12(2):133-40. PubMed ID: 20218749
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of colesevelam HCl in the treatment of elderly patients.
Gavin JR; Jones MR; Ford DM; Truitt KE
Drugs Aging; 2014 Jun; 31(6):461-70. PubMed ID: 24777691
[TBL] [Abstract][Full Text] [Related]
15. Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol.
Corsini A; Windler E; Farnier M
Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):1-9. PubMed ID: 19237992
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.
Jones MR; Mudaliar S; Hernandez-Triana E; Unnikrishnan AG; Lai YL; Abby SL; Misir S; Jin X; Nagendran S
Curr Med Res Opin; 2009 Sep; 25(9):2239-49. PubMed ID: 19622007
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of colesevelam hydrochloride for the treatment of type 2 diabetes.
Younk LM; Davis SN
Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):515-25. PubMed ID: 22432790
[TBL] [Abstract][Full Text] [Related]
18. Review of studies on the effect of bile acid sequestrants in patients with type 2 diabetes mellitus.
Levy P
Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1():S9-13. PubMed ID: 20946010
[TBL] [Abstract][Full Text] [Related]
19. Colesevelam: a review of its use in hypercholesterolemia.
Robinson DM; Keating GM
Am J Cardiovasc Drugs; 2007; 7(6):453-65. PubMed ID: 18076213
[TBL] [Abstract][Full Text] [Related]
20. Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes.
Goldfine AB; Fonseca VA; Jones MR; Wang AC; Ford DM; Truitt KE
Horm Metab Res; 2010 Jan; 42(1):23-30. PubMed ID: 19862667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]